↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

e.g. Sirolimus, アダリムマブ

ABCDEFGH I JKLMNOPQRSTUVWXYZother

55 / 17,542 descriptions

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes		 指定難病告示番号
1 5% lidocaine/5 mg/ml 0.02% estradiol compound cream Estradiol 11件: D00105, D00358, D01413, D01617, D01953, D02086, D04061, D04063, D04064, D04065, D08127 💬 7件: ESR1, ESR2, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 12件: Adrenergic signaling in cardiomyocytes, Breast cancer, Dopaminergic synapse, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Taste transduction, Thyroid hormone signaling pathway 1件: 226 💬
2 A-dopamine Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
3 Alkalinized lidocaine-heparin Heparin 4件: D00358, D02086, D07510, D08127 💬 6件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction 1件: 226 💬
4 Behavioral: role of dopamine Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
5 Bladder instillation with heparin/ lidocaine Heparin 4件: D00358, D02086, D07510, D08127 💬 6件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction 1件: 226 💬
6 Bromocriptine and other dopamine agonists Bromocriptine 4件: D00633, D00780, D03165, D07870 💬 6件: DRD1, DRD2, DRD3, DRD4, DRD5, PRL 💬 15件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
7 Bupivacaine Bupivacaine 2件: D01450, D07552 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 8件: 46, 51, 53, 70, 96, 168, 226, 298 💬
8 Bupivacaine hydrochloride Bupivacaine 2件: D01450, D07552 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 2件: 46, 53 💬
9 Bupivacaine hydrochloride 0.5% (marcaine, pfizer) Bupivacaine 2件: D01450, D07552 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件: 46 💬
10 Bupivacaine injection 0.5% Bupivacaine 2件: D01450, D07552 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件: 168 💬
11 Bupivacaine/epinephrine/dexamethasone Bupivacaine 14件: D00095, D00292, D00975, D00996, D01450, D01510, D01615, D01632, D01948, D02149, D02174, D02591, D02592, D07552 💬 15件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 96 💬
12 Ceftazidime Ceftazidime 2件: D00921, D07654 💬 - - 1件: 299 💬
13 Ceftazidime and tobramycin Ceftazidime 4件: D00063, D00921, D02542, D07654 💬 - - 1件: 299 💬
14 Ceftazidime pentahydrate Ceftazidime 2件: D00921, D07654 💬 - - 1件: 299 💬
15 Ceftazidime/avibactam Avibactam 2件: D00921, D07654 💬 - - 1件: 299 💬
16 Ceftriaxone Ceftriaxone 2件: D00924, D07659 💬 - - 3件:  2 ,  6 , 97 💬
17 Cefuroxime Cefuroxime 4件: D00262, D00914, D00915, D03431 💬 - - 2件: 97, 299 💬
18 Cerebral dopamine neurotrophic factor Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
19 Clindamycin Clindamycin 4件: D00277, D01073, D01990, D02132 💬 - - 2件: 46, 299 💬
20 Conivaptan Conivaptan 2件: D01236, D07748 💬 2件: AVPR1A, AVPR2 💬 5件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 1件: 86 💬
21 Continuous infusion ceftazidime Ceftazidime 2件: D00921, D07654 💬 - - 1件: 299 💬
22 Continuous release dopamine agonists Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
23 Dextrose Dextrose, unspecified form - - - 4件: 56, 60, 65, 70 💬
24 Dextrose, 5% in water Dextrose, unspecified form 1件: D00001 💬 - - 1件: 65 💬
25 Dobutamine Dobutamine 4件: D00632, D03879, D03880, D03881 💬 1件: ADRB1 💬 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 3件: 57, 58, 215 💬
26 Dopamine Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 3件:  6 ,  7 , 74 💬
27 Dopamine agent Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
28 Dopamine agonist treatment Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件: 74 💬
29 Dopamine agonists Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件: 74 💬
30 Dopamine agonists (pramipexole, ropirinole) Dopamine 4件: D00559, D00633, D05575, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
31 Ercp with bupivacaine infusion Bupivacaine 2件: D01450, D07552 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件: 298 💬
32 Heparin & alkalinized lidocaine bladder instillation Heparin 4件: D00358, D02086, D07510, D08127 💬 6件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction 1件: 226 💬
33 Intermittent, short infusion ceftazidime Ceftazidime 2件: D00921, D07654 💬 - - 1件: 299 💬
34 Iv ceftazidime Ceftazidime 2件: D00921, D07654 💬 - - 1件: 299 💬
35 Lap tap bupivacaine/epinephrine Bupivacaine 5件: D00095, D00996, D01450, D02149, D07552 💬 14件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 96 💬
36 Lidocaine Lidocaine 3件: D00358, D02086, D08127 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 10件:  6 , 13, 34, 46, 51, 86, 168, 226, 231, 256 💬
37 Lidocaine 1% injectable solution Lidocaine 3件: D00358, D02086, D08127 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件: 34 💬
38 Lidocaine 2% without vessel constrictor Lidocaine 3件: D00358, D02086, D08127 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件: 51 💬
39 Lidocaine injection 2% Lidocaine 3件: D00358, D02086, D08127 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件: 168 💬
40 Lidocaine patch 5% Lidocaine 3件: D00358, D02086, D08127 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件: 13 💬
41 Lidocaine releasing intravesical system - liris® Lidocaine 3件: D00358, D02086, D08127 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件: 226 💬
42 Liposomal bupivacaine Bupivacaine 2件: D01450, D07552 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 3件: 51, 70, 96 💬
43 Local anesthesia (lidocaine hydrochloride) Lidocaine 3件: D00358, D02086, D08127 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件:  6  💬
44 Magnesium sulfate Magnesium 1件: D01108 💬 - - 3件: 11, 296, 297 💬
45 Nitroglycerin Nitroglycerin 1件: D00515 💬 - - 1件: 51 💬
46 Nitroglycerin ointment 2% Nitroglycerin 1件: D00515 💬 - - 1件: 51 💬
47 Other: dextrose water 5% Dextrose, unspecified form 1件: D00001 💬 - - 1件: 56 💬
48 Other: dobutamine Dobutamine 4件: D00632, D03879, D03880, D03881 💬 1件: ADRB1 💬 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 215 💬
49 Procedure: embryonic dopamine cell implant surgery Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
50 Prolotherapy solution of 20% dextrose Dextrose, unspecified form - - - 1件: 70 💬
51 Recombinant human cerebral dopamine neurotrophic factor Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
52 Spironolactone and conivaptan Conivaptan 3件: D00443, D01236, D07748 💬 3件: AVPR1A, AVPR2, NR3C2 💬 6件: Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 1件: 86 💬
53 Topical amphimatrix with nitroglycerin (mqx-503) Nitroglycerin 1件: D00515 💬 - - 1件: 51 💬
54 Topical organogel with nitroglycerin Nitroglycerin 1件: D00515 💬 - - 1件: 51 💬
55 Us tap bupivacaine/epinephrine Bupivacaine 5件: D00095, D00996, D01450, D02149, D07552 💬 14件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 96 💬

先頭へ